Ribavirin® is administered to a patient in a dosage range which is effective to modulate lymphokine expression in activated T cells. In particular, Ribavirin® is used to suppress Th2-mediated T cell responses and promote Th1-mediated T cell response. In other apsects of the invention, one or more Ribavirin® analogs are administered to a patient in a dosage range which is effective to modulate lymphokine expression in activated T cells. The Ribavirin® analog(s) may be used to suppress or enhance Th1 or Th2-mediated T cell responses.
利巴韦林®给患者的剂量范围可有效调节活化 T 细胞中淋巴因子的表达。特别是,
利巴韦林®可用于抑制Th2介导的T细胞反应,促进Th1介导的T细胞反应。在本发明的其他部分中,向患者施用一种或多种
利巴韦林® 类似物,其剂量范围可有效调节活化 T 细胞中淋巴因子的表达。
利巴韦林® 类似物可用于抑制或增强 Th1 或 Th2 介导的 T 细胞反应。